COMMUNIQUÉS West-GlobeNewswire
 
      -   
  Delcath’s CHEMOSAT Included in German Treatment Guidelines for Melanoma Liver Metastases16/05/2018
-   
  Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2018 Financial Results16/05/2018
-   
  Chembio Diagnostics Names John Potthoff, Ph.D. to its Board of Directors16/05/2018
-   
  EY Announces that Sabrina Martucci Johnson, CEO of Daré Bioscience, Inc., is an Entrepreneur Of The Year® 2018 Award Finalist in San Diego16/05/2018
-   
  Agritek Holdings Inc. Announces Timely Filing of Quarterly Report, Now Focused On Revenue, Acquisitions, and International Growth For Profitability in 201816/05/2018
-   
  Insmed Announces FDA Acceptance for Filing of New Drug Application for ALIS in NTM Lung Disease Caused by MAC16/05/2018
-   
  PolarityTE Announces Rich Haerle as the New Vice President of Investor Relations and Corporate Strategy16/05/2018
-   
  Prostate cancer discovery enabled by Biolog technology16/05/2018
-   
  ADMA Biologics Granted U.S. Patent for Treating Respiratory Infections16/05/2018
-   
  K2M Announces US Launch of First-to-Market 3D-Printed Expandable Interbody MOJAVE™ PL 3D Expandable Featuring Lamellar 3D Titanium Technology™16/05/2018
-   
  ObsEva Reports First Quarter 2018 Financial Results and Provides Business Update16/05/2018
-   
  Evolus to Provide Regulatory Update on Wednesday, May 16, 201816/05/2018
-   
  Aclaris Therapeutics Announces Poster Presentations at International Investigative Dermatology 2018 Meeting16/05/2018
-   
  EyePoint Pharmaceuticals Announces Appointment of Leonard Blum as Executive Vice President and General Manager, U.S.16/05/2018
-   
  ESPERITE NV (ESP) WITH CRYOSAVE TAKES OVER FULL CONTROL OF BUSINESS IN SOUTH AFRICA AND INTEND TO DISTRIBUTE ADVANCED SERVICES TO THE GROWING AFRICAN POPULATION16/05/2018
-   
  LIDDS: Delårsrapport januari-mars 201816/05/2018
-   
  Terveystalo Plc: Terveystalo Group Interim Report January 1 - March 31, 201816/05/2018
-   
  Kiadis Pharma to Present at Upcoming Investor Conferences16/05/2018
-   
  Shire plc: Rule 2.9 Announcement16/05/2018
Pages